Elanco

Elanco Animal Health Incorporated is an American pharmaceutical company which produces medicines and vaccinations for pets and livestock. Until 2019, the company was a subsidiary of Eli Lilly and Company, before being divested.

Elanco Animal Health Incorporated
TypePublic
NYSE: ELAN
IndustryPharmaceutical (animal)
Founded1954 
HeadquartersGreenfield, Indiana, U.S.
Key people
R. David Hoover (Chairman)
Jeff Simmons (CEO)
ProductsPharmaceutical drugs (animal)
Number of employees
6,080 (December 2019)
Websiteelanco.com

History

The company can trace its roots back to the mid-1950s when Eli Lilly introduced their first antibiotic aimed at veterinary usage with the new plant and animal sciences research being combined into Lilly's Agro-Industrial division. In the 1960s the Agro-Industrial division was reorganised, launching Elanco Products Company.[1]

The 1970s marked a decade of expansion for the business, increasing international operations to 38 global affiliates and 17 manufacturing locations. In the 1980s research moved to away from plant sciences and focussed on animal health and food quality. In the 1990s another reorganisation led to the company being renamed Elanco Animal Health, focussing solely on animal health.[1]

In 2007 the business acquired Ivy Animal Health and launched its companion animal business. In 2008 Elanco partnered with Heifer International in order to address food security in developing nations. In 2009 the business launched its data analytics business, Elanco Knowledge Solutions.[1]

In 2010 the business acquired the European rights to a portfolio of Pfizer Animal Health treatments and an Irish manufacturing site.[2] In 2011, Elanco expanded its footprint in Europe, acquiring Janssen Animal Health[3] and committed to ending hunger for 100,000 families through the Heifer International partnership. In 2012 the business acquired ChemGen Corp.,[4] improving their offering in enzyme-based nutrient absorption tools for food-livestock. In 2014, the business acquired Lohmann SE and Lohmann Animal Health for an undisclosed sum[5] and Novartis Animal Health for $5.4 billion, the former boosting Elanco's poultry and vaccine business and the latter increasing a broad spectrum of treatments across companion animal, livestock, vaccine and aquaculture offerings. In 2016 Elanco expanded its US-based business, acquiring a suite of vaccines from Boehringer Ingelheim Vetmedica[6] for $885 million.[7][8]

In 2018, Lilly announced plans to separate its Elanco Animal Health unit from the rest of the business via an initial public offering on the New York Stock Exchange, with the stock-ticker ELAN. In 2019, the divestiture was completed and Elanco launched on the New York Stock Exchange. In the same year the US FDA approved the first canine lymphoma treatment. The business continued to expand is US-business, acquiring Aratana Therapeutics,[9] and its first-in-class treatment for canine osteoarthritis. Elanco also announced it would acquire the developer of vaccines for bacterial disease prevention in food-animals, Prevtec Microbia, Inc..[10] In the same year the business announced it would acquire Bayer’s animal health business for $7.6 billion.[11][12][13]

On December 3, 2020, Elanco announced plans to build a new global headquarters in Indianapolis at the site of the former GM stamping plant, which is located across the White River from the downtown area. The business plans to break ground on the new headquarters in the first half of 2021.[14]

Acquisitions
Eli Lilly and Company Acquisitions

References
  1. "About Elanco | Solutions for Protecting and Enhancing Animal Health". www.elanco.com.
  2. "Lilly to Acquire European Rights to Pfizer Animal Health Assets". www.elanco.com.
  3. "Lilly Makes an Irrevocable Offer to Acquire Janssen Animal Health". www.elanco.com.
  4. "Elanco Animal Health Announces Lilly's Agreement to Acquire ChemGen Corp". www.elanco.com.
  5. "Elanco Announes Agreement to Acquire Lohmann Animal Health". www.elanco.com.
  6. "Lilly Finalizes Novartis Animal Health Acquisition". www.elanco.com.
  7. "Elanco Animal Health Completes Acquisition of Boehringer Ingelheim Vetmedica's U.S. Feline, Canine and Rabies Vaccines Portfolio". www.elanco.com.
  8. "Elanco Animal Health Enters Agreement to Acquire Boehringer Ingelheim Vetmedica's U.S. Feline, Canin, and Rabies Vaccines Portfolio". www.elanco.com.
  9. "Elanco Announces Agreement to Acquire Aratana Therapeutics; Completes Oncology Development Agreement with VetDC, Creates Specialty Veterinary Business Focus". www.elanco.com.
  10. "Elanco Announces Acquisition of Prevtec Microbia Swine Vaccine Company". www.elanco.com.
  11. "Elanco to divest brands, forgo Canadian rights for Bayer's unit deal". 14 July 2020 – via uk.reuters.com.
  12. "Elanco Animal Health wins approval to buy Bayer unit". 15 July 2020 – via uk.reuters.com.
  13. "Elanco Announces Agreement to Acquire Bayer's Animal Health Business". www.elanco.com.
  14. Burris, Alexandria. "Former GM stamping plant will be home to Elanco Animal Health headquarters". The Indianapolis Star. Retrieved 5 December 2020.
  15. "Eli Lilly and Company Announces Acquisition of Ivy Animal Health". PRNewswire. 25 May 2007.
  16. "Lilly to Acquire European Rights to Pfizer Animal Health Assets". PRNewswire. 8 March 2010.
  17. "Lilly Makes an Irrevocable Offer to Acquire Janssen Animal Health". PRNewswire. 14 March 2011.
  18. "Elanco Animal Health Announces Lilly's Agreement to Acquire ChemGen Corp". PRNewswire. 24 January 2012.
  19. "Elanco Announces Agreement to Acquire Lohmann Animal Health". PRNewswire. 24 February 2014.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.